Susquehanna International Group, LLP Embecta Corp. Call Options Transaction History

Susquehanna International Group, LLP

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 07, 2024	SELL	$12.35 - $19.33 $40,755 - $63,788	-3,300 Reduced 12.94%	22,200 $294,000
Q4 2023 Feb 14, 2024	BUY	$12.87 - $19.09 $164,736 - $244,352	12,800 Added 100.79%	25,500 $482,000
Q3 2023 Nov 14, 2023	BUY	$15.0 - $22.17 $190,500 - $281,559	12,700 New	12,700 $191,000
Q1 2023 May 16, 2023	SELL	$23.07 - $32.77 $1.07 Million - $1.52 Million	-46,500 Reduced 61.84%	28,700 $807,000
Q4 2022 Feb 14, 2023	BUY	$25.29 - $35.48 $1.3 Million - $1.83 Million	51,500 Added 217.3%	75,200 $1.9 Million

Q3 2022 Nov 14, 2022	BUY	$24.0 - $33.42 $208,800 - $290,754	8,700 Added 58.0%	23,700 $682,000
Q2 2022 Aug 15, 2022	BUY	$24.78 - $33.36 $371,700 - $500,400	15,000 New	15,000 $380,000

392

52.2M

45.7K

49K

Ticker EMBC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 57,836,500
Market Cap $723M
Description
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.